Skip to main content

Silvia Sánchez Martín

Institutions of which they are part

Postdoctoral researcher
Neuromuscular and Mitochondrial Pathology
Vall Hebron Institut de Recerca

Silvia Sánchez Martín

Institutions of which they are part

Postdoctoral researcher
Neuromuscular and Mitochondrial Pathology
Vall Hebron Institut de Recerca

Related news

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

The newly developed analytical workflow could in the future be introduced as a comprehensive diagnostic test for patients with mitochondrial diseases.

Related professionals

Núria García Doladé

Núria García Doladé

Predoctoral researcher
Clinical Pharmacology
Read more
Giulio Bonaldo

Giulio Bonaldo

Research technician
Biomedical Research in Gynaecology
Read more
Laura Roman Pons

Laura Roman Pons

Research technician
Clinical Neuroimmunology
Read more
Jordi Sabadell García

Jordi Sabadell García

General Surgery
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.